規(guī)格:50μL/100μL
貨號:PN0121
價格:1350元/50μL;2200元/100 μL
全稱 | Anti-CD3 epsilon |
別名 | CD3epsilon antibody IMD18 antibody T cell antigen receptor complex epsilon subunit of T3 antibody T3E antibody TCRE antibody |
抗體來源 | Rabbit |
克隆類型 | Monoclonal |
交叉反應 | Mouse, Rat, Human |
產(chǎn)品應用 | WB:1/500 IP:1:25 IHC-P:1:2500 |
理論分子量 | 23kDa |
細胞定位 | 細胞膜 |
性 狀 | Liquid |
濃 度 | 0.25 mg/ml |
免 疫 原 | N/A |
亞 型 | IgG |
純化方法 | Protein A |
Uniprot ID | |
緩 沖 液 | PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300 |
保存條件 | 12 months from date of receipt / reconstitution, -20 °C as supplied |
注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
背景
CD3 (cluster of differentiation 3) is a protein complex and T cell co-receptor that is involved in activating both the cytotoxic T cell (CD8+ naive T cells) and T helper cells (CD4+ naive T cells). It is composed of four distinct chains. In mammals, the complex contains a CD3γ chain, a CD3δ chain, and two CD3ε chains. These chains associate with the T-cell receptor (TCR) and the CD3-zeta (ζ-chain) to generate an activation signal in T lymphocytes. The TCR, CD3-zeta, and the other CD3 molecμLes together constitute the TCR complex. The CD3–T cell receptor (TCR) complex plays a central role in the T-cell-mediated immunoresponse as it is involved in the recognition of antigens and subsequent signal transduction and activation of immunocompetent T lymphocytes. Because CD3 is required for T cell activation, drugs (often monoclonal antibodies) that target it are being investigated as immunosuppressant therapies (e.g., otelixizumab, teplizumab) for type 1 diabetes and other autoimmune diseases.